Description
NABOTA 150U Botulinum Toxin Type A is a botulinum toxin type A product from NABOTA, listed for registered Australian clinics in our Toxins range. Pack: see product images for pack format. Priced in AUD (A$161.00). Sydney dispatch, nationwide. Not a public treatment clinic.
About NABOTA 150U Botulinum Toxin Type A
NABOTA 150U Botulinum Toxin Type A
Indication:
- Temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients (Approved in KR, US, EU, Canada)
- Treatment of upper limb spasticity in adult patients (Approved in KR)
- Temporary improvement in the appearance of moderate to severe lateral canthal lines associated with orbicularis oculi activity in adult patients (Approved in KR)
- Treatment of blepharospasm associated with dystonia in adult patients (Approved in KR)
- HI Pure™ Technology (KR patent No.13-39349, US Patent No. 9,512,418)
Nabota is a premium, high-purity Botulinum Toxin Type A developed by Daewoong Pharmaceutical in South Korea for treating fine lines, wrinkles, and muscle tightness. It acts as a faster-acting, often more affordable alternative to Botox, with results appearing within 2–3 days and lasting 4–6 months
- FDA Approval: Approved in the U.S. in 2019, confirming strict safety and efficacy standards.
- International Approval: Approved by the Korean FDA (MFDS) in 2013, EMA in Europe (as Newtox), and Health Canada.
- Global Presence: Approved in over 60 countries, including Australia (as Nuceiva).
- Manufacturing Quality: Produced in accordance with WHO Good Manufacturing Practices (GMP).
Clinical Efficacy & Safety:
- Purpose: Primarily used for treating glabellar frown lines, it has a fast onset, with improvements often visible within 2–5 days.
- Safety Profile: Clinical trials show high efficacy, with common side effects being mild, such as headache or localized pain.
- Administration: It must be administered by licensed medical professionals
NABOTA 150U Botulinum Toxin Type A — key details for ordering
- Product: NABOTA 150U Botulinum Toxin Type A
- Brand: NABOTA
- Category: Toxins > NABOTA
- Pack format: see product images for pack format
- Price: A$161.00 AUD, including GST where applicable
- Dispatch: Sydney, Australia-wide
Using NABOTA 150U Botulinum Toxin Type A in clinic practice
Store unopened vials refrigerated as the manufacturer directs and reconstitute only with the diluent and volumes stated in the product documentation. Toxin products are prescription-only where Australian law requires it, and dosing units differ between brands, so check the unit strength on this page against the vial you currently use before ordering.
Ordering NABOTA 150U Botulinum Toxin Type A and related products
Compare NABOTA 150U Botulinum Toxin Type A with Botulax 100/200 botulinum toxin A, NABOTA 100U/200U Purified Botulinum Toxin Type A Complex, Re N Tox Type A toxin (100U/200U), or browse the full Toxins catalogue. Clinics ordering in volume can use our wholesale enquiry program (AUD $5,000 minimum). See also the clinic FAQ and delivery information. Active-ingredient background for NABOTA 150U Botulinum Toxin Type A is covered in the reference article on Botulinum toxin, and Australian practitioners should confirm regulatory positionings with the TGA before use.
